[go: up one dir, main page]

HRP20000003A2 - Il-5 inhibiting 6-azauracil derivatives - Google Patents

Il-5 inhibiting 6-azauracil derivatives

Info

Publication number
HRP20000003A2
HRP20000003A2 HR20000003A HRP20000003A HRP20000003A2 HR P20000003 A2 HRP20000003 A2 HR P20000003A2 HR 20000003 A HR20000003 A HR 20000003A HR P20000003 A HRP20000003 A HR P20000003A HR P20000003 A2 HRP20000003 A2 HR P20000003A2
Authority
HR
Croatia
Prior art keywords
inhibiting
azauracil derivatives
azauracil
derivatives
Prior art date
Application number
HR20000003A
Other languages
English (en)
Inventor
Jean Fernand Armand Lacrampe
Eddy Jean Edgard Freyne
Marc Gaston Venet
Gustaaf Maria Boeckx
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HRP20000003A2 publication Critical patent/HRP20000003A2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/061,2,4-Triazines
    • C07D253/0651,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/071,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075Two hetero atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HR20000003A 1997-07-10 1998-07-07 Il-5 inhibiting 6-azauracil derivatives HRP20000003A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97202118 1997-07-10
PCT/EP1998/004191 WO1999002505A1 (en) 1997-07-10 1998-07-07 Il-5 inhibiting 6-azauracil derivatives

Publications (1)

Publication Number Publication Date
HRP20000003A2 true HRP20000003A2 (en) 2000-12-31

Family

ID=8228531

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000003A HRP20000003A2 (en) 1997-07-10 1998-07-07 Il-5 inhibiting 6-azauracil derivatives

Country Status (23)

Country Link
EP (1) EP1000040B1 (pt)
JP (1) JP2002511882A (pt)
KR (1) KR20010014049A (pt)
CN (1) CN1262679A (pt)
AR (1) AR013360A1 (pt)
AT (1) ATE364597T1 (pt)
AU (1) AU742145B2 (pt)
BR (1) BR9811678A (pt)
CA (1) CA2294145A1 (pt)
DE (1) DE69837922D1 (pt)
EE (1) EE200000016A (pt)
HR (1) HRP20000003A2 (pt)
HU (1) HUP0004687A3 (pt)
ID (1) ID24390A (pt)
IL (1) IL133916A0 (pt)
NO (1) NO20000063L (pt)
NZ (1) NZ502180A (pt)
PL (1) PL337947A1 (pt)
SK (1) SK183999A3 (pt)
TR (1) TR200000153T2 (pt)
TW (1) TW496865B (pt)
WO (1) WO1999002505A1 (pt)
ZA (1) ZA986089B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277609T1 (de) * 1998-07-30 2004-10-15 Abbott Lab Glucocorticoid selektive entzündungshemmende mittel
EP0987265A1 (en) 1998-09-18 2000-03-22 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
UA73107C2 (en) 1998-12-18 2005-06-15 Janssen Pharmaceutica Nv Derivatives of 6-azaurcyle inhibiting il-5
HRP20020096A2 (en) * 1999-08-06 2005-10-31 Janssen Pharmaceutica N.V. Interleukin-5 inhibiting 6-azauracil derivatives
US6743820B2 (en) 2000-07-07 2004-06-01 University Of Toledo Methods for protection of stratified squamous epithelium against injury by noxious substances and novel agents for use therefor
US7183276B2 (en) 2002-02-28 2007-02-27 Takeda Pharmaceutical Company Limited Azole compounds
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
GB0305575D0 (en) 2003-03-11 2003-04-16 Glaxo Group Ltd Novel compounds
US20080119456A1 (en) * 2004-05-29 2008-05-22 Trond Ulven Substituted Thiazoleacetic Acid as Crth2 Ligands
DE102006049618A1 (de) * 2006-10-20 2008-05-08 Tschesche, Harald, Prof. Dr. Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren
CN101265238B (zh) * 2007-12-12 2010-06-16 重庆天极旅业有限公司 一种三嗪环衍生物的合成方法
CN101265216B (zh) * 2007-12-18 2012-06-27 重庆华邦胜凯制药有限公司 4-(取代乙氰基)-苯腙衍生物及其合成方法
AP2013006678A0 (en) * 2010-08-16 2013-01-31 Boehringer Ingelheim Int Oxadiazole inhibitors of leukotriene production
EP3943088A1 (en) * 2016-07-13 2022-01-26 Université de Paris Diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by p. acnes
US20220289692A1 (en) * 2019-09-06 2022-09-15 Inflazome Limited Nlrp3 inhibitors
CN120346211B (zh) * 2025-06-20 2025-10-24 中国科学技术大学 二苯乙腈类化合物的用途及蛋白质靶向水解嵌合体类化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149645A1 (de) * 1970-10-07 1972-09-14 Pfizer 2-Phenyl-as-triazin-3.5-(2H,4H)-dione und die Verwendung dieser Verbindungen zur Bekaempfung der Coccidiose
US3912723A (en) * 1971-03-29 1975-10-14 Pfizer 2-Phenyl-as-triazine-3,5(2H,4H)diones
US3883528A (en) * 1974-04-19 1975-05-13 Pfizer Preparation of 2(aryl)-as-triazine-3,5(2H,4H)-dione coccidiostats
CA1244024A (en) * 1984-08-01 1988-11-01 Gustaaf M. Boeckx .alpha.- ARYL-4-(4,5-DIHYDRO-3,5-DIOXO-1,2,4-TRIAZIN- 2(3H)-YL)BENZENEACETONITRILES
GB8602342D0 (en) * 1986-01-30 1986-03-05 Janssen Pharmaceutica Nv 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones
EP0476439A1 (de) * 1990-09-18 1992-03-25 Bayer Ag Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung
TW403741B (en) * 1993-10-15 2000-09-01 Takeda Chemical Industries Ltd Triazine derivative, production and use thereof

Also Published As

Publication number Publication date
NO20000063D0 (no) 2000-01-06
KR20010014049A (ko) 2001-02-26
WO1999002505A1 (en) 1999-01-21
DE69837922D1 (de) 2007-07-26
NO20000063L (no) 2000-03-10
JP2002511882A (ja) 2002-04-16
TW496865B (en) 2002-08-01
AR013360A1 (es) 2000-12-27
NZ502180A (en) 2000-11-24
EE200000016A (et) 2000-10-16
AU742145B2 (en) 2001-12-20
CN1262679A (zh) 2000-08-09
ATE364597T1 (de) 2007-07-15
ZA986089B (en) 2000-01-10
ID24390A (id) 2000-07-13
BR9811678A (pt) 2000-09-19
SK183999A3 (en) 2000-08-14
HUP0004687A3 (en) 2002-03-28
HUP0004687A2 (hu) 2002-02-28
CA2294145A1 (en) 1999-01-21
EP1000040B1 (en) 2007-06-13
IL133916A0 (en) 2001-04-30
PL337947A1 (en) 2000-09-11
TR200000153T2 (tr) 2000-07-21
AU8973898A (en) 1999-02-08
EP1000040A1 (en) 2000-05-17

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
IL141226A0 (en) 1h-imidazopyridine derivatives
GB9702194D0 (en) Sulphonide derivatives
PL345540A1 (en) Thiobenzimidazole derivatives
HRP990011B1 (en) Benzosulfone derivatives
GB9910384D0 (en) Alpha-ketoamide derivatives
HRP20000003A2 (en) Il-5 inhibiting 6-azauracil derivatives
EG23802A (en) 2-Phenylpyran-4-one derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
IL133915A0 (en) 6-azauracil derivatives as il-5 inhibitors
GB9827729D0 (en) Thieno-indole derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
GB9701427D0 (en) Gemcitabine derivatives
IL143766A (en) Il-5 inhibiting 6-azauracil derivatives
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
EP1061912A4 (en) PHENANTHROFURANDERIVATE
IL139276A0 (en) Cyclohexenondioxthio chromanoyl derivatives
HK1025094A (en) Il-5 inhibiting 6-azauracil derivatives
ATE289596T1 (de) Il-5 hemmende 6-azauracilderivate
GB9706753D0 (en) Aralkoxy-morphinan derivatives
HK1038348A (en) Interleukin-5 inhibiting 6-azauracil derivatives
HK1025095A (en) 6-azauracil derivatives as il-5 inhibitors
GB9816279D0 (en) Arylthiazolidinedione derivatives

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20020707

Year of fee payment: 5

OBST Application withdrawn